Drug Profile
Research programme: anti epithelial cell adhesion molecule antibodies - Affitech A/S
Alternative Names: AT 003; EpCAM AntibodiesLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Affitech A/S
- Class Antibodies
- Mechanism of Action Epithelial cell adhesion molecule inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Norway
- 03 Aug 2009 Preclinical trials in Cancer in Norway (unspecified route)